Stay updated on Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision v3.3.3 added; HHS Vulnerability Disclosure and Revision v3.3.2 removed.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedThe record history now includes a new revision entry (v3.3.2) replacing the previous revision (v3.2.0). There are no changes to study details or status.SummaryDifference0.1%

- Check56 days agoChange DetectedThe funding status notice that previously appeared on the page was removed.SummaryDifference0.4%

- Check70 days agoChange DetectedNew screenshot shows an extended list of version history entries with updated recruitment and study status across multiple versions. The changes reflect more recent updates to the study record.SummaryDifference0.1%

- Check99 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference10%

- Check106 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combos Post-Chemo-Radiation in Lung Cancer Clinical Trial page.